Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancer. Issue 4 (August 2019)

• Record Type: Journal Article
• Authors: Machens, Andreas; Dralle, Henning
• Is Part Of: Best practice & research. Volume 33:Issue 4(2019)
• Publication Date: 2019-08
• Subjects: RET proto-oncogene -- DNA-based screening -- medullary thyroid carcinoma -- lymph node metastasis -- prophylactic thyroidectomy -- biochemical cure; Endocrine glands -- Diseases -- Periodicals; Metabolism -- Disorders -- Periodicals; Endocrinology -- Periodicals; Metabolism -- Periodicals; 616.4
• DOI: 10.1016/j.beem.2019.04.008
• Languages: English
• ISSNs: 1521-690X

Abstract

Abstract : Advances in sequencing technology, providing unprecedented insights into cancer progression, have shifted the treatment paradigm towards precision medicine for hereditary medullary thyroid cancer (MTC), away from the ' one-size-fits-all ' approach predicated on genetic risk alone. The DNA-based/biochemical concept, factoring serum calcitonin into the benefit–risk equation, optimizes biochemical cure while minimizing extent of prophylactic surgery and operative morbidity in children at risk. The transformative effect that has taking effect on medical practice has been impressive: Increasingly earlier molecular diagnosis and more limited prophylactic neck operations yielded excellent clinical outcomes at expert facilities 7–16 years postoperatively: biochemical cure rates approximating 100%; absence of residual structural disease or recurrence; and rarely any permanent operative morbidity. These excellent results, contingent on proper health care funding and pediatric surgical specialization, make a case for early prophylactic thyroidectomy in experienced hands once calcitonin serum levels exceed the upper normal limit of the assay in young gene carriers.